Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (111-120 of 303) with videos related to

Pageof 31
Sort By:
Clinical Genitourinary Cancer|October 12, 2015
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial CarcinomaYoung Saing Kim, Soon Il Lee, Se Hoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial TumorsHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|March 18, 2017
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with <i>EGFR</i>-Mutant Non-small Cell Lung CancerJong Ho Cho, Wei Zhou, Yoon-La Choi, et al.
Oral Oncology|June 29, 2011
Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckJong-Mu Sun, Hyun Jung Jun, Young Hyeh Ko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factorsSu Jin Lee, Jung-Il Lee, Do-Hyun Nam, et al.
Journal of Translational Medicine|October 26, 2014
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinomaBo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumorSeung Hwan Moon, Hae Su Kim, Young Seok Cho, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiencyKi Hyang Kim, Ho Young Kim, Hye Ryun Kim, et al.
Pageof 31

Showing results (111-120 of 303) with videos related to

Sort By:
Pageof 31
Clinical Genitourinary Cancer|October 12, 2015
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial CarcinomaYoung Saing Kim, Soon Il Lee, Se Hoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial TumorsHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|March 18, 2017
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with <i>EGFR</i>-Mutant Non-small Cell Lung CancerJong Ho Cho, Wei Zhou, Yoon-La Choi, et al.
Oral Oncology|June 29, 2011
Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckJong-Mu Sun, Hyun Jung Jun, Young Hyeh Ko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factorsSu Jin Lee, Jung-Il Lee, Do-Hyun Nam, et al.
Journal of Translational Medicine|October 26, 2014
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinomaBo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumorSeung Hwan Moon, Hae Su Kim, Young Seok Cho, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiencyKi Hyang Kim, Ho Young Kim, Hye Ryun Kim, et al.
Pageof 31